BioCentury

7:00 AM GMT, Oct 31, 2016
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Sofosbuvir/velpatasvir/voxilaprevir: Phase III data

Top-line data from the open-label, international Phase III POLARIS-2 trial in 941 patients with chronic HCV genotypes 1-6 infection

Read the full 199 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.